Chronic stable angina clinical subset- syndrome X: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 9: Line 9:
*Syndrome X is defined as the '''presence of typical anginal chest pain with angiographically normal coronary arteries.'''   
*Syndrome X is defined as the '''presence of typical anginal chest pain with angiographically normal coronary arteries.'''   


*Although the syndrome originally referred to patients in whom the [[chest pain]] was due to non coronary causes, the current, stricter definition limits it to those patients who appear to have true [[myocardial ischemia]] despite epicardial coronary arteries that are normal or nearly so on coronary angiography.
*Although the syndrome originally referred to patients where the [[chest pain]] was due to non coronary causes, the current, stricter definition limits it to those patients who appear to have true [[myocardial ischemia]] despite epicardial coronary arteries that are normal or closely on coronary angiography.


*To establish the diagnosis, patients must have evidence of [[myocardial ischemia]] by exercise [[ECG]], [[stress scintigraphy]], or [[stress echocardiography]] in conjunction with anginal chest discomfort.
*To establish the diagnosis, patients must have evidence of [[myocardial ischemia]] by exercise [[ECG]], [[stress scintigraphy]], or [[stress echocardiography]] in conjunction with anginal chest discomfort.
:*Some of these patients have documented reductions in coronary vasodilator reserve presumably due to abnormalities in the [[coronary microcirculation]] and can be shown to have true [[ischemia]] because their [[myocardium]] produces rather than removes lactate during stress.  
:*Some of these patients have documented reductions in coronary vasodilator reserve presumably due to abnormalities in the [[coronary microcirculation]] and can be shown to have true [[ischemia]] because their [[myocardium]] produces lactate rather than removing it during stress.  


*The syndrome may be more common in patients with hypertrophied myocardium secondary to any cause.  
*The syndrome may be more common in patients with hypertrophied myocardium, secondary to any cause.  


*The prognosis in terms of major coronary events appears to be benign.
*The prognosis in terms of major coronary events appears to be benign.

Revision as of 14:35, 21 July 2011

Chronic stable angina Microchapters

Acute Coronary Syndrome Main Page

Home

Patient Information

Overview

Historical Perspective

Classification

Classic
Chronic Stable Angina
Atypical
Walk through Angina
Mixed Angina
Nocturnal Angina
Postprandial Angina
Cardiac Syndrome X
Vasospastic Angina

Differentiating Chronic Stable Angina from Acute Coronary Syndromes

Pathophysiology

Epidemiology and Demographics

Risk Stratification

Pretest Probability of CAD in a Patient with Angina

Prognosis

Diagnosis

History and Symptoms

Physical Examination

Test Selection Guideline for the Individual Basis

Laboratory Findings

Electrocardiogram

Exercise ECG

Chest X Ray

Myocardial Perfusion Scintigraphy with Pharmacologic Stress

Myocardial Perfusion Scintigraphy with Thallium

Echocardiography

Exercise Echocardiography

Computed coronary tomography angiography(CCTA)

Positron Emission Tomography

Ambulatory ST Segment Monitoring

Electron Beam Tomography

Cardiac Magnetic Resonance Imaging

Coronary Angiography

Treatment

Medical Therapy

Revascularization

PCI
CABG
Hybrid Coronary Revascularization

Alternative Therapies for Refractory Angina

Transmyocardial Revascularization (TMR)
Spinal Cord Stimulation (SCS)
Enhanced External Counter Pulsation (EECP)
ACC/AHA Guidelines for Alternative Therapies in patients with Refractory Angina

Discharge Care

Patient Follow-Up
Rehabilitation

Secondary Prevention

Guidelines for Asymptomatic Patients

Noninvasive Testing in Asymptomatic Patients
Risk Stratification by Coronary Angiography
Pharmacotherapy to Prevent MI and Death in Asymptomatic Patients

Landmark Trials

Case Studies

Case #1

Chronic stable angina clinical subset- syndrome X On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Chronic stable angina clinical subset- syndrome X

CDC onChronic stable angina clinical subset- syndrome X

Chronic stable angina clinical subset- syndrome X in the news

Blogs on Chronic stable angina clinical subset- syndrome X

to Hospitals Treating Chronic stable angina clinical subset- syndrome X

Risk calculators and risk factors for Chronic stable angina clinical subset- syndrome X

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]

Overview

One of the clinical subsets of angina [1] is described below.

Syndrome X

  • Syndrome X is defined as the presence of typical anginal chest pain with angiographically normal coronary arteries.
  • Although the syndrome originally referred to patients where the chest pain was due to non coronary causes, the current, stricter definition limits it to those patients who appear to have true myocardial ischemia despite epicardial coronary arteries that are normal or closely on coronary angiography.
  • Some of these patients have documented reductions in coronary vasodilator reserve presumably due to abnormalities in the coronary microcirculation and can be shown to have true ischemia because their myocardium produces lactate rather than removing it during stress.
  • The syndrome may be more common in patients with hypertrophied myocardium, secondary to any cause.
  • The prognosis in terms of major coronary events appears to be benign.

ESC Guidelines for investigation in patients with Syndrome X (DO NOT EDIT)[2]

Class I

1. Resting echocardiogram in patients with angina and normal or non-obstructed coronary arteries to assess for presence of ventricular hypertrophy and/or diastolic dysfunction. (Level of Evidence: C)

Class IIb

1. Intracoronary acetylcholine during coronary arteriography, if the arteriogram is visually normal, to assess endothelium-dependent coronary flow reserve, and exclude vasospasm. (Level of Evidence: C)

2. Intracoronary ultrasound, coronary flow reserve, or FFR measurement to exclude missed obstructive lesions, if angiographic appearances are suggestive of a nonobstructive lesion rather than completely normal, and stress imaging techniques identify an extensive area of ischaemia. (Level of Evidence: C)

ESC Guidelines for pharmacological therapy to improve symptoms in patients with Syndrome X (DO NOT EDIT)[2]

Class I

1. Therapy with nitrates, beta blockers, and calcium channel blockers alone or in combination. (Level of Evidence: B)

2. Statin therapy in patients with hyperlipidaemia. (Level of Evidence: B)

3. ACE inhibitors in patients with hypertension. (Level of Evidence: C)

Class IIa

1. Trial of therapy with other anti-anginals including nicorandil and metabolic agents. (Level of Evidence: C)

Class IIb

1. Aminophylline for continued pain, despite Class I measures. (Level of Evidence: C)

2. Imipramine for continued pain, despite Class I measures. (Level of Evidence: C)

Sources

  • Guidelines on the management of stable angina pectoris: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology [2]

References

  1. Braunwald, Eugene (2003). Primary Cardiology. Saunders. ISBN 0-7216-9444-6. Unknown parameter |coauthors= ignored (help)
  2. 2.0 2.1 2.2 Fox K, Garcia MA, Ardissino D, Buszman P, Camici PG, Crea F; et al. (2006). "Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology". Eur Heart J. 27 (11): 1341–81. doi:10.1093/eurheartj/ehl001. PMID 16735367.


Template:WikiDoc Sources